Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, irritation and swollen, reddened eyelids. Other symptoms include enlarged nose, thickening the skin on the nose, (rhinophyma). Rosacea predominantly affects middle-aged women having fair skin.

This report contains market size and forecasts of Rosacea Treatments in UK, including the following market information:

UK Rosacea Treatments Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in UK Rosacea Treatments Market 2019 (%)

The global Rosacea Treatments market was valued at 1526 million in 2019 and is projected to reach US$ 1721.7 million by 2026, at a CAGR of 3.1% during the forecast period. While the Rosacea Treatments market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Rosacea Treatments businesses, with lots of challenges and uncertainty faced by many players of Rosacea Treatments in UK. This report also analyses and evaluates the COVID-19 impact on Rosacea Treatments market size in 2020 and the next few years in UK


Total Market by Segment:

UK Rosacea Treatments Market, By Type, 2015-2020, 2021-2026 ($ millions)

UK Rosacea Treatments Market Segment Percentages, By Type, 2019 (%)

Topical

Orals

UK Rosacea Treatments Market, By Application, 2015-2020, 2021-2026 ($ millions)

UK Rosacea Treatments Market Segment Percentages, By Application, 2019 (%)

Drugs Stores

Hospital

Other


Competitor Analysis

The report also provides analysis of leading market participants including:

Total Rosacea Treatments Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)

Total Rosacea Treatments Market Competitors Revenues Share in UK, by Players 2019 (%)


Further, the report presents profiles of competitors in the market, including the following:

Nestle Skin Health

Teva

Mylan

Bayer

Sun Pharma

Perrigo

Bausch Health

GSK

Pfizer

Allergan